Paraneoplastic pemphigus: A case report and review of literature

Oral Diseases

Volumn 11, Issue 5, 2005, Pages 326-329

  Tilakaratne, W M ^a   Dissanayake, M ^b  

^a UNIVERSITY OF PERADENIYA   (Sri Lanka)

^b Teaching Hospital Kandy   (Sri Lanka)

Author keywords

Immunofluorescence; Neoplastic; Oral mucosa; Paraneoplastic; Pemphigus; Refractory

Indexed keywords

PREDNISOLONE; ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CARCINOMA; CASE REPORT; CLINICAL FEATURE; DRUG ERUPTION; FEMALE; GENITAL ULCER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LYMPHOPROLIFERATIVE DISEASE; MEDICAL LITERATURE; MELANOMA; MOUTH ULCER; NONHODGKIN LYMPHOMA; PARANEOPLASTIC PEMPHIGUS; PARANEOPLASTIC SYNDROME; PEMPHIGUS; PRIORITY JOURNAL; RARE DISEASE; SARCOMA; SKIN TUMOR; STEVENS JOHNSON SYNDROME; CONJUNCTIVITIS; FLUORESCENT ANTIBODY TECHNIQUE; PATHOLOGY;

ADULT; ANTI-INFLAMMATORY AGENTS; CONJUNCTIVITIS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; LYMPHOMA, NON-HODGKIN; ORAL ULCER; PARANEOPLASTIC SYNDROMES; PEMPHIGUS;

EID: 25144514069     PISSN: 1354523X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2005.01116.x     Document Type: Article

References (14)

1. Anhalt GL (1997). Paraneoplastic pemphigus. Adv Dermatol 12: 77-96.
2. Anhalt GL, Kim SC, Stanley JR et al (1990). Paraneoplastic pemphigus: an autoimmune mucocutaneous disease. N Engl J Med 323: 1729-1735.
3. Bazarbachi A, Bachelez H, Dehen L et al (1995). Lethal paraneoplastic pemphigus following treatment of chronic lymphocytic leukaemia with fludarabine. Ann Oncol 6: 730-731.
4. Dega H, Laporte JL, Joly P et al (1998). Paraneoplastic pemphigus associated with Hodgkin's disease. Br J Dermatol 138: 196-198.
5. Hashimoto T (2001). Immunopathology of paraneoplastic pemphigus. Clin Dermatol 19: 675-682.
6. Helm TN, Camisa C, Valenzuela R et al (1993). Paraneoplastic pemphigus. A distinct autoimmune vesiculobullous disorder associated with neoplasia. Oral Surg Oral Med Oral Pathol 75: 209-213.
7. Joly P, Richard C, Gilbert D et al (2000). Sensitivity and specificity of clinical, histopathologic and immunologic features in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol 43: 619-626.
8. Kaplan I, Hodak E, Ackerman L et al (2004). Neoplasms associated with paraneoplastic pemphigus: a review of literature with emphasis on non-haematologic malignancy and oral manifestations. Oral oncology 40: 553-562.
9. Kimyai-Asai A, Jih MH (2001). Paraneoplastic pemphigus. Int J Dermatol 40: 367-372.
10. Lee IJ, Kim SC, Kim HS et al (1999). Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma arising from Castleman tumour. J Am Acad Dermatol 40: 294-297.
11. Mimouni D, Anhalt GL, Lazarova Z et al (2002). Paraneoplastic pemphigus in children and adolescents. Brit J Dermatol 147: 725-732.
12. Morris DL, Saywell MS, Strutton GM et al (1993). Pemphigus vulgaris associated with spindle cell thymoma. Australias J Dermatol 34: 97-102.
13. Robinson ND, Hashimoto T, Amagi M et al (1999). Continuing medical education: the new pemphigus variants. J Am Acad Dermatol 40: 649-671.
14. Schadlow MB, Anhalt GJ, Sinha AA (2003). Using rituximab (anti-CD 20 antibody) in a patient with papraneoplastic pemphigus. J Drugs Dermatol 2: 564-567.